title: Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix.
abstract: Although monocyte- and macrophage-derived molecules are known to promote extracellular matrix (ECM) disruption and destabilization, it is less appreciated that they also synthesize molecules contributing to ECM formation, stabilization, and function. We have identified and characterized the synthesis of proteoglycans and related proteins, some not previously known to be associated with macrophages. Proteoglycan extracts of [(35)S]sulfate- and (35)S-trans amino acid-radiolabeled culture media from THP-1 monocytes induced to differentiate by treatment with phorbol myristate acetate revealed three major proteins of ~25, 90, and 100 kDa following chondroitin ABC lyase digestion. The 25-kDa protein was predominant for monocytes, whereas the 90- and 100-kDa proteins were predominant for macrophages. Tandem mass spectrometry identified (i) the 25-kDa core protein as serglycin, (ii) the 90-kDa core protein as inter-α-inhibitor heavy chain 2 (IαIHC2), and (iii) the 100-kDa core as amyloid precursor-like protein 2 (APLP2). Differentiation was also associated with (i) a >500-fold increase in mRNA for TNF-stimulated gene-6, an essential cofactor for heavy chain-mediated matrix stabilization; (ii) a >800-fold increase in mRNA for HAS2, which is responsible for hyaluronan synthesis; and (iii) a 3-fold increase in mRNA for versican, which interacts with hyaluronan. Biochemical evidence is also presented for an IαIHC2-APLP2 complex, and immunohistochemical staining of human atherosclerotic lesions demonstrates similar staining patterns for APLP2 and IαIHC2 with macrophages, whereas serglycin localizes to the underlying glycosaminoglycan-rich region. These findings indicate that macrophages synthesize many of the molecules participating in ECM formation and function, suggesting a novel role for these molecules in the differentiation of macrophages in the development of atherosclerosis.
authors.affiliation: Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington 98195, USA.
authors.forename: Mary Y
authors.initials: MY
authors.lastname: Chang
authors.forename: Christina K
authors.initials: CK
authors.lastname: Chan
authors.forename: Kathleen R
authors.initials: KR
authors.lastname: Braun
authors.forename: Pattie S
authors.initials: PS
authors.lastname: Green
authors.forename: Kevin D
authors.initials: KD
authors.lastname: O'Brien
authors.forename: Alan
authors.initials: A
authors.lastname: Chait
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Day
authors.forename: Thomas N
authors.initials: TN
authors.lastname: Wight
mesh_terms: D050197:Atherosclerosis / Q000473:pathology; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002454:Cell Differentiation; D005109:Extracellular Matrix / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000737:chemistry; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D007249:Inflammation; D008264:Macrophages / Q000166:cytology*; D009000:Monocytes / Q000166:cytology*; D011509:Proteoglycans / Q000737:chemistry; D053719:Tandem Mass Spectrometry / Q000379:methods; D014357:Trypsin / Q000737:chemistry; D053675:Versicans / Q000378:metabolism; D033921:Vesicular Transport Proteins / Q000737:chemistry
chemical_list: D015815:Cell Adhesion Molecules; D006025:Glycosaminoglycans; D011509:Proteoglycans; C072273:TNFAIP6 protein, human; D033921:Vesicular Transport Proteins; C075430:serglycin; D053675:Versicans; D006820:Hyaluronic Acid; D014357:Trypsin